Company Announcements Chromatide announced further investments by Enterprise Ventures and Alliance Fund Managers. GE Healthcare is collaborating with Celestial Biologicals to set up India’s first GMP-compliant fully integrated chromatography-based plasma fractionation facility. The facility is based in Ahmedabad. Agilent is providing technical support for the development of Aurora SFC Systems’ Fusion A5, which converts HPLC […]

FoodProcessing.com estimates that capital spending by the top 20, publicly held, US food and beverage companies will decline 2.9% this year. Eleven of the 20 firms plan to increase capital spending in 2009. In some cases, the companies are planning to do so because of acquisitions, including Ralcorp and J.M. Smucker. Of the 11 companies […]

Microfluidics, or lab-on-a-chip systems, have been somewhat pigeonholed as being a technology for capillary electrophoresis, particularly with the success of the Agilent 2100 Bioanalyzer and Caliper Life Sciences’ LabChip products. However, the use of microfluidic technology in LC has grown rapidly during the past several years. Agilent introduced the first chip-based LC/MS system in 2005, […]

Longjumeau, France 4/20/09—Horiba Jobin Yvon has acquired GenOptics, a provider of surface plasmon resonance imaging technology (SPRi) for label-free detection for an undisclosed amount. “In the coming years we will see the merging of biotechnology and microtechnology to create combinations of ultra integrated devices on a molecular scale” stated Dr. Michel Mariton, HORIBA Scientific segment […]

Waltham, MA 4/22/09—Phase Forward, a supplier of clinical trials software, has acquired Waban Software for $14 million in cash. Waban’s products include clinical data analysis systems, as well as lab information and clinical specimen management systems. In 2008, Waban had $4 million in revenues and break even operating income. Based in Cambridge, Massachusetts, with operations […]

This year, the EPA will begin to implement the Endocrine Disruptor Screening Program (EDSP), which was established in 1998. Initially, 67 pesticide active ingredients and high-production volume chemicals used as pesticide inert ingredients will be screened. Tier 1 of the EDSP will screen the substances for interactions with estrogen, androgen or thyroid hormone systems. Substances […]

In its fiscal budget released this month, the UK announced the creation of a $1.1 billion Strategic Investment Fund. The Fund is designed to support exports, R&D and investment in the UK. The Technology Strategy Board will receive $72 million from the Fund to invest in potential high-growth fields, such as life sciences and low […]

Company Announcements Caprotec bioanalytics GmbH named Funakoshi as the exclusive distributor of its research products in Japan. Agilent announced in February that it will exclusively distribute and provide marketing and support for Protein Discovery’s PPS Silent Surfactant, an acid-cleavable, zwitterionic detergent for sample preparation prior to MS. In February, OriGene Technologies announced that it raised […]

IMS Health forecasts the global pharmaceutical market to grow 2.5%–3.5% in 2009, excluding currency effects, to more than $750 billion. This is down from the previous estimate of 4.5%–5.5% growth (see IBO 10/31/08). Compound annual growth for 2009 through 2013 is estimated to be 3%–6%. IMS observed that consumers are less likely to start new […]